Use of diclofenac in children with asthma
2000; Wiley; Volume: 55; Issue: 4 Linguagem: Inglês
10.1046/j.1365-2044.2000.01280.x
ISSN1365-2044
AutoresJ. A. Short, Catriona Barr, Christopher Douglas Palmer, John M Goddard, C.G. Stack, R A Primhak,
Tópico(s)Inhalation and Respiratory Drug Delivery
ResumoThis study investigated the effect of diclofenac on the lung function of 70 children aged 6–15 years with a diagnosis of asthma, recruited from a hospital respiratory clinic. Peak flow and a forced expiratory flow‐volume loop were measured and the patients were then given 1–1.5 mg.kg −1 effervescent diclofenac orally. Spirometry was repeated at 10, 20 and 30 min, a 15% decrease in results being considered a significant reduction in lung function. No patient demonstrated a consistent reduction in lung function of > 15% during the study and there were no reports of wheezing or increased bronchodilator use after completion of the spirometry. In conclusion, we studied a group of genuine asthmatics and found no clinically significant incidence of bronchospasm with the use of a single therapeutic dose of diclofenac.
Referência(s)